Immunization of non-Hodgkin lymphoma patients with a novel recombinant idiotype vaccine: Results from a phase I clinical trial

被引：0
|
作者：
Bertinetti, C [1 ]
Dierbach, H [1 ]
Mauerer, K [1 ]
Mikesch, K [1 ]
Veelken, H [1 ]
机构：
[1] Univ Freiburg, Med Ctr, Dept Hematol Oncol, D-7800 Freiburg, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 2005年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
78
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [1] Immune responses and clinical outcome of patients with advanced non-Hodgkin's lymphoma after immunization with a novel recombinant idiotype vaccine.
    Veelken, H
    Mauerer, K
    Mikesch, K
    Osterroth, F
    Rosenthal, FM
    Thomas, AK
    Bertinetti, C
    BLOOD, 2003, 102 (11) : 898A - 898A
  • [2] A phase I/II trial to evaluate the immunogenicity of recombinant idiotype protein vaccines for the treatment of non-Hodgkin's lymphoma (NHL).
    Timmerman, J
    Czerwinski, D
    van Beckhoven, A
    Vose, J
    Ingolia, D
    Kunkel, L
    Denney, D
    Levy, R
    BLOOD, 2000, 96 (11) : 578A - +
  • [3] Idiotype vaccination for patients with Non-Hodgkin's Lymphoma
    Caspar, CB
    Hsu, FJ
    Davis, TA
    Czerwinski, D
    Kwak, LW
    Liles, TM
    Syrengelas, A
    Taidi, B
    Levy, R
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 30 - 30
  • [4] Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses
    Redfern, Charles H.
    Guthrie, Troy H.
    Bessudo, Alberto
    Densmore, John J.
    Holman, Peter R.
    Janakiraman, Nalini
    Leonard, John P.
    Levy, Richard L.
    Just, Richard G.
    Smith, Mitchell R.
    Rosenfelt, Fred P.
    Wiernik, Peter H.
    Carter, William D.
    Gold, Daniel P.
    Melink, Teresa J.
    Gutheil, John C.
    Bender, John F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3107 - 3112
  • [5] A phase 2 study demonstrating recombinant idiotype vaccine elicits specific anti-idiotype immune responses in aggressive non-Hodgkin's lymphoma.
    Timmerman, J
    Vose, J
    Kunkel, L
    Bierman, P
    Czerwinski, D
    Hohenstein, M
    Ingolia, D
    Denney, D
    Levy, R
    BLOOD, 2001, 98 (11) : 341A - 341A
  • [6] Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma
    Abbasi, MR
    Sparano, JA
    Sarta, C
    Wiernik, PH
    MEDICAL ONCOLOGY, 2003, 20 (01) : 53 - 58
  • [7] Phase I trial of fludarabine and paclitaxel in non-hodgkin’s lymphoma
    Muhammad R. Abbasi
    Joseph A. Sparano
    Catherine Sarta
    Peter H. Wiernik
    Medical Oncology, 2003, 20 : 53 - 58
  • [8] Phase I trials begin for personalized non-Hodgkin's lymphoma vaccine
    不详
    EXPERT REVIEW OF VACCINES, 2010, 9 (03) : 237 - 237
  • [9] Phase I trials begin for personalized non-Hodgkin's lymphoma vaccine
    不详
    IMMUNOTHERAPY, 2010, 2 (02) : 141 - 141
  • [10] Clinical remissions in previously untreated patients with follicular lymphoma after intradermal immunization with a recombinant idiotype vaccine
    Mikesch, K
    Bertinetti, C
    Veelken, H
    ANNALS OF ONCOLOGY, 2005, 16 : 72 - 72
12345